Cosara Diagnostics gets CDSCO license to manufacture SARAGENE Dengue Test Kit

CoSara is a joint venture company of Synbiotics Limited, a wholly owned subsidiary Ambalal Sarabhai Enterprises Limited and Co- Diagnostics Inc, USA.

Sep 17, 2021 09:09 IST India Infoline News Service

Stock Market Trader, Stock Trader, Trading
Cosara Diagnostics Pvt Ltd has announced regarding regulatory approval obtained from CDSCO (Central Drugs Standard Control Organisation) to manufacture and sell SARAGENE Dengue Test Kit. The tests are now available for sale.

Accordingly, SARAGENE Dengue Test Kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics’ patented a CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014).

It tests and for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.

CoSara is a joint venture company of Synbiotics Limited, a wholly owned subsidiary Ambalal Sarabhai Enterprises Limited and Co- Diagnostics Inc, USA.

On Sensex, Ambalal Sarabhai Enterprises was trading at Rs31 apiece up by Rs1.45 or 4.91%, at around 9:33 AM.

Related Story

Open Free Demat Account (Rs699)